Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Gene and Protein Information ![]() |
||||||
| Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
| Human | - | 1019 | 10q23.33 | IDE | insulin degrading enzyme | |
| Mouse | - | 1019 | 19 32.24 cM | Ide | insulin degrading enzyme | |
| Rat | - | 1019 | 1q53 | Ide | insulin degrading enzyme | |
Previous and Unofficial Names ![]() |
| INSDEGM | insulin protease | insulinase | insulysin |
Database Links ![]() |
|
| Specialist databases | |
| MEROPS | M16.982 (Hs) |
| Other databases | |
| Alphafold | P14735 (Hs), Q9JHR7 (Mm), P35559 (Rn) |
| BRENDA | 3.4.24.56 |
| ChEMBL Target | CHEMBL1293287 (Hs), CHEMBL3232680 (Mm) |
| DrugBank Target | P14735 (Hs) |
| Ensembl Gene | ENSG00000119912 (Hs), ENSMUSG00000056999 (Mm), ENSRNOG00000016833 (Rn) |
| Entrez Gene | 3416 (Hs), 15925 (Mm), 25700 (Rn) |
| Human Protein Atlas | ENSG00000119912 (Hs) |
| KEGG Enzyme | 3.4.24.56 |
| KEGG Gene | hsa:3416 (Hs), mmu:15925 (Mm), rno:25700 (Rn) |
| OMIM | 146680 (Hs) |
| Pharos | P14735 (Hs) |
| RefSeq Nucleotide | NM_001165946 (Hs), NM_004969 (Hs), NM_031156 (Mm), NM_013159 (Rn) |
| RefSeq Protein | NP_004960 (Hs), NP_001159418 (Hs), NP_112419 (Mm), NP_037291 (Rn) |
| SynPHARM |
82443 (in complex with NTE-1) 82444 (in complex with NTE-2) 82445 (in complex with quinoline 2) |
| UniProtKB | P14735 (Hs), Q9JHR7 (Mm), P35559 (Rn) |
| Wikipedia | IDE (Hs) |
Selected 3D Structures ![]() |
|||||||||||||
|
|
||||||||||||
|
|
||||||||||||
|
|
||||||||||||
Enzyme Reaction ![]() |
||||
|
||||
Download all structure-activity data for this target as a CSV file
| Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. Durham TB, Toth JL, Klimkowski VJ, Cao JX, Siesky AM, Alexander-Chacko J, Wu GY, Dixon JT, McGee JE, Wang Y et al.. (2015) Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo. J Biol Chem, 290 (33): 20044-59. [PMID:26085101]
M16: Pitrilysin: insulin degrading enzyme. Last modified on 30/03/2016. Accessed on 29/10/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2371.